Welcome to our dedicated page for Electromed SEC filings (Ticker: ELMD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page compiles U.S. Securities and Exchange Commission filings for Electromed, Inc. (NYSE American: ELMD), a Minnesota-based medical device company that develops, manufactures, and sells airway clearance therapy products such as the SmartVest® Airway Clearance System. These regulatory documents provide detailed insight into Electromed’s financial condition, governance, and material corporate events.
Through periodic reports like the Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, Electromed discloses information on its revenues from direct homecare and non-homecare markets, gross profit, operating expenses, research and development, and net income. These filings also describe risk factors related to reimbursement, regulatory compliance, competition, component supply, and other aspects of operating in the medical device industry.
Current Reports on Form 8-K document specific events, such as the announcement of quarterly and annual financial results, updates to investor presentations, approval of share repurchase authorizations, and the entry into a Credit Agreement with BMO Bank N.A. that provides a senior secured revolving credit facility. Other 8-K filings cover shareholder meeting results, including director elections, auditor ratification, and advisory votes on executive compensation.
The Definitive Proxy Statement on Form DEF 14A offers additional detail on corporate governance, board composition, executive and director compensation, equity compensation plans, and the procedures for the annual meeting of shareholders, which Electromed has conducted as a virtual meeting via webcast.
On Stock Titan, Electromed’s SEC filings are available with AI-powered summaries that highlight key points from lengthy documents, helping users quickly understand topics such as revenue drivers, capital allocation decisions, credit facility terms, and governance matters. Real-time updates from EDGAR ensure that new 10-K, 10-Q, 8-K, DEF 14A, and related filings, as well as any insider transaction reports on Form 4, are accessible with clear explanations of their significance for ELMD shareholders and analysts.
Electromed, Inc. disclosed that it has issued a press release reporting its financial results for the fourth quarter and fiscal year ended June 30, 2025, and furnished that press release as Exhibit 99.1 to this Form 8-K. The company also updated its investor presentation and furnished it as Exhibit 99.2, noting that the presentation may be used in meetings with investors and analysts.
The filing provides notice that the company has made results and updated presentation materials available to the market, but it does not include the financial metrics or narrative from the press release within the filing itself; interested parties must refer to the referenced exhibits for the detailed results and figures.